These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 7835639)

  • 1. Effects of fencamfamine withdrawal in rats.
    Planeta CS; DeLucia R; Aizenstein ML
    Gen Pharmacol; 1994 Sep; 25(5):931-4. PubMed ID: 7835639
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Repeated administration intensifies the reinforcing effect of fencamfamine in rats.
    DeLucia R; Planeta CS; Aizenstein ML; Scavone C
    Gen Pharmacol; 1997 Aug; 29(2):265-7. PubMed ID: 9251911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The behavioral sensitization induced by fencamfamine is not related to plasma drug levels.
    Planeta CS; DeLucia R; Aizenstein ML
    Braz J Med Biol Res; 1995 Jun; 28(6):667-70. PubMed ID: 8547850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Circadian time-dependent effects of fencamfamine on inhibition of dopamine uptake and release in rat striatal slices.
    DeLucia R; Planeta CS; Ferreira MP; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1997 May; 30(5):637-40. PubMed ID: 9283632
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of fencamfamine on latent inhibition.
    Alves CR; Delucia R; Silva MT
    Prog Neuropsychopharmacol Biol Psychiatry; 2002 Oct; 26(6):1089-93. PubMed ID: 12452530
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reinforcing properties of fencamfamine: involvement of dopamine and opioid receptors.
    Planeta Cda S; Aizenstein ML; DeLucia R
    Pharmacol Biochem Behav; 1995 Jan; 50(1):35-40. PubMed ID: 7700952
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of dopamine and serotonin receptor antagonists on fencamfamine-induced abolition of latent inhibition.
    de Aguiar CR; de Aguiar MJ; DeLucia R; Silva MT
    Eur J Pharmacol; 2013 Jan; 698(1-3):246-51. PubMed ID: 23123352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fencamfamine-induced changes in the parameters of the matching law and the effect of previous exposure to the drug.
    Garcia-Mijares M; Delucia R; Silva MT
    Behav Pharmacol; 2004 Dec; 15(8):577-84. PubMed ID: 15577456
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of apomorphine on rat motor activity induced by fencamfamine and other indirect psychostimulant drugs.
    Aizenstein ML; da-Silva-Planeta C; DeLucia R; da-Silva CS
    Braz J Med Biol Res; 1995 Sep; 28(9):995-8. PubMed ID: 8580889
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fencamfamine modulates sodium, potassium-ATPase through cyclic AMP and cyclic AMP-dependent protein kinase in rat striatum.
    Pinto Ferreira M; DeLucia R; Luiz Aizenstein M; Glezer I; Scavone C
    J Neural Transm (Vienna); 1998; 105(6-7):549-60. PubMed ID: 9826101
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effects of chronic treatment with fencamfamine on body weight, food intake and stereotyped behaviour in rats.
    DeLucia R; Aizenstein ML; Scavone C; Planeta Cda S
    Gen Pharmacol; 1987; 18(3):299-301. PubMed ID: 2883072
    [TBL] [Abstract][Full Text] [Related]  

  • 12. On the mechanism which mediates the effects of long-term administration of fencamfamine in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Scavone C
    Braz J Med Biol Res; 1989; 22(7):881-3. PubMed ID: 2576524
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Behavioral and neurochemical effects of fencamfamine on rats: a chronobiologic approach.
    Planeta Cda S; Aizenstein ML; Scavone C; DeLucia R
    Chronobiol Int; 1989; 6(4):313-20. PubMed ID: 2483362
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of environmental enrichment during induction of methamphetamine dependence on the behavioral withdrawal symptoms in rats.
    Hajheidari S; Miladi-Gorji H; Bigdeli I
    Neurosci Lett; 2015 Sep; 605():39-43. PubMed ID: 26275348
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Daily variation in plasma concentration of fencamfamine and striatal dopamine receptors in rats.
    Planeta CS; DeLucia R; Aizenstein ML; Oliveira GH
    Braz J Med Biol Res; 1994 Mar; 27(3):737-41. PubMed ID: 8081299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Reduction of food intake by fencamfamine in rats.
    DeLucia R; Planeta Cda S; Scavone C; Aizenstein ML
    Gen Pharmacol; 1987; 18(1):21-3. PubMed ID: 2881832
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential effects on prepulse inhibition of withdrawal from two different repeated administration schedules of amphetamine.
    Peleg-Raibstein D; Sydekum E; Feldon J
    Int J Neuropsychopharmacol; 2006 Dec; 9(6):737-49. PubMed ID: 16448582
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sensitivity to Chronic Methamphetamine Administration and Withdrawal in Mice with Relaxin-3/RXFP3 Deficiency.
    Haidar M; Lam M; Chua BE; Smith CM; Gundlach AL
    Neurochem Res; 2016 Mar; 41(3):481-91. PubMed ID: 26023064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of psychostimulant withdrawal on latent inhibition of conditioned active avoidance and prepulse inhibition of the acoustic startle response.
    Murphy CA; Di Iorio L; Feldon J
    Psychopharmacology (Berl); 2001 Jul; 156(2-3):155-64. PubMed ID: 11549217
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blockade of neurotensin receptors during amphetamine discontinuation indicates individual variability.
    Costa FG; Frussa-Filho R; Canteras NS; Valera AG; Felicio LF
    Neuropeptides; 2007 Apr; 41(2):83-91. PubMed ID: 17276509
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.